Yahoo · Oct 23, 2026
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
NASDAQ · AGL
Healthcare · Medical - Care Facilities
$86.63
Up+$1.73 (+2.04%)
Updated Nov 3, 2026, 11:30 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AGL
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
AGL closed at $86.63 after 21 trading sessions, up 2.79% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $86.12 | $88.07 | $83.775 | $86.63 | 281.53K |
| Oct 30, 2026 | $84.31 | $85.495 | $82.24 | $84.90 | 217.46K |
| Oct 29, 2026 | $90.59 | $92.85 | $85.22 | $85.94 | 138.59K |
| Oct 28, 2026 | $89.40 | $94.2002 | $89.40 | $91.00 | 232.15K |
| Oct 27, 2026 | $91.50 | $91.50 | $88.15 | $90.65 | 123.84K |
| Oct 26, 2026 | $89.55 | $93.24 | $88.72 | $90.34 | 175.94K |
| Oct 23, 2026 | $89.60 | $90.37 | $85.37 | $89.71 | 189.6K |
| Oct 22, 2026 | $89.71 | $93.15 | $87.69 | $90.29 | 184.31K |
| Oct 21, 2026 | $91.17 | $93.855 | $88.68 | $90.99 | 208.69K |
| Oct 20, 2026 | $89.40 | $94.37 | $88.225 | $91.72 | 165.34K |
| Oct 19, 2026 | $85.67 | $89.53 | $85.67 | $88.83 | 217.6K |
| Oct 16, 2026 | $88.90 | $89.06 | $84.70 | $85.12 | 123.16K |
| Oct 15, 2026 | $86.59 | $88.64 | $85.57 | $88.45 | 137.43K |
| Oct 14, 2026 | $84.08 | $87.40 | $84.08 | $87.40 | 145.32K |
| Oct 13, 2026 | $86.36 | $87.09 | $83.42 | $85.90 | 153.33K |
| Oct 12, 2026 | $81.74 | $86.495 | $81.16 | $85.49 | 158.67K |
| Oct 9, 2026 | $85.68 | $88.125 | $82.36 | $82.39 | 171.88K |
| Oct 8, 2026 | $84.07 | $84.83 | $82.06 | $84.72 | 222.36K |
| Oct 7, 2026 | $81.99 | $87.84 | $81.99 | $85.70 | 355.69K |
| Oct 6, 2026 | $85.14 | $86.2625 | $82.99 | $83.40 | 168.55K |
| Oct 5, 2026 | $83.28 | $85.825 | $82.60 | $84.28 | 188.13K |
The latest Smart Investors Daily articles mentioning AGL.
Company
Market Activity
Research & News
AGL research
Company profile and research snapshot.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 15, 2026 | Bernstein | Outperform | — |
| Aug 24, 2026 | JP Morgan | Underweight | — |
| Aug 11, 2026 | Wells Fargo | Overweight | — |
| Aug 11, 2026 | Citigroup | Neutral | — |
| Aug 6, 2026 | Evercore ISI Group | In-Line | — |
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
Yahoo · Oct 21, 2026
What a time it’s been for agilon health. In the past six months alone, the company’s stock price has increased by a massive 275%, reaching $91.76 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Yahoo · Oct 16, 2026
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
Yahoo · Oct 8, 2026
How the Jackson Clinic expansion reframes agilon health’s Medicare footprint Agilon health (AGL) just expanded its partnership with The Jackson Clinic, bringing the practice into its Senior Health Connect ACO and extending value-based care reach to roughly 9,000 additional Traditional Medicare beneficiaries. The move plugs a long-standing partner that already works with about 8,000 Medicare Advantage seniors into a program that participates in the Medicare Shared Savings Program. For...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning AGL.